West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript October 23, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceutical Services Inc (WST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 1,799 | $471,932 | +243% | 0.22% |
| 2. | Sivik Global Healthcare Krishen Sud | 15,000 | $3,935 | 1.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $105.14 | 54 | $5,677.40 | 66,251 | 2019-02-28 | Filing | |
| $110.55 | 57 | $6,301.52 | 66,197 | 2018-07-31 | Filing | |
| $93.94 | 335 | $31,468.79 | 66,475 | 2017-10-17 | Filing | |
| $88.89 | 275 | $24,444.31 | 56,540 | 2018-05-15 | Filing | |
| $84.53 | 332 | $28,063.30 | 51,831 | 2016-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $310.40 | 225 | $69,840.00 | 1,253 | 2024-10-29 | Filing | |
| $310.40 | 478 | $148,371.20 | 1,478 | 2024-10-29 | Filing | |
| $300.00 | 500 | $150,000.00 | 1,478 | 2024-08-19 | Filing | |
| $300.00 | 529 | $158,700.00 | 1,978 | 2024-08-19 | Filing | |
| $365.92 | 617 | $225,772.64 | 43,565 | 2024-05-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 362,540 | $95,105,248 | 1.6% | |
| 2. | 326,957 | $85,770,630 | 6.2% | |
| 3. | 188,867 | $49,545,480 | 0.07% | |
| 4. | 163,000 | $42,759,688 | 2.39% | |
| 5. | 136,470 | $35,800,175 | 1.51% |
News See All
What Makes West Pharmaceutical Services (WST) a Prospective Investment?
Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here.
Improved Investor Confidence Boosted West Pharmaceutical Services (WST)
Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Should You Be Optimistic on West Pharmaceutical (WST)?
Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2025 Earnings Call Transcript July 24, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks
West Pharmaceutical Services Inc. (NYSE:WST) is one of the most oversold S&P 500 stocks so far in 2025.
10 Most Oversold S&P 500 Stocks So Far in 2025
The S&P 500 Index has delivered a strong performance in 2025 as it has climbed over 7% and reached new all-time highs.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on WST.
Is West Pharmaceutical Services (WST) a Great Business Unfairly Sold Off by the Market?
Brasada Capital Management, an investment management company, released its Q2 2025 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services (WST) Fell on Lowered Guidance
Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center Billionaire Hedge Funds
